Back to Search Start Over

A low FEV1 confounds interpretation of FeNO as an eligibility criterion for dupilumab

Authors :
Alain Michils
Alain Van Muylem
Amaryllis Haccuria
Jeremy Cofino Casanueva
Lucas Demey
Andrei Malinovschi
Silvia Perez-Bogerd
Source :
The Journal of Allergy and Clinical Immunology: In Practice. 10:615-616.e1
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Details

ISSN :
22132198
Volume :
10
Database :
OpenAIRE
Journal :
The Journal of Allergy and Clinical Immunology: In Practice
Accession number :
edsair.doi...........4de0c62f230902af3f78fe3fc23896fb
Full Text :
https://doi.org/10.1016/j.jaip.2021.09.020